Tools for assessing quality of studies investigating health interventions using real-world data: a literature review and content analysis

被引:0
|
作者
Jiu, Li [1 ]
Hartog, Michiel [1 ]
Wang, Junfeng [1 ]
Vreman, Rick A. [1 ]
Klungel, Olaf H. [1 ]
Mantel-Teeuwisse, Aukje K. [1 ]
Goettsch, Wim G. [1 ,2 ]
机构
[1] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands
[2] Natl Hlth Care Inst, Diemen, Netherlands
来源
BMJ OPEN | 2024年 / 14卷 / 02期
关键词
Systematic Review; EPIDEMIOLOGY; HEALTH ECONOMICS; SYSTEMATIC REVIEWS; REPORTING QUALITY; PUBLIC-HEALTH; RISK; CARE; BIAS; REPRODUCIBILITY; RECOMMENDATIONS; COMPLEMENTARY; APPRAISAL;
D O I
10.1136/bmjopen-2023-075173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We aimed to identify existing appraisal tools for non-randomised studies of interventions (NRSIs) and to compare the criteria that the tools provide at the quality-item level.Design Literature review through three approaches: systematic search of journal articles, snowballing search of reviews on appraisal tools and grey literature search on websites of health technology assessment (HTA) agencies.Data sources Systematic search: Medline; Snowballing: starting from three articles (D'Andrea et al, Quigley et al and Faria et al); Grey literature: websites of European HTA agencies listed by the International Network of Agencies for Health Technology Assessment. Appraisal tools were searched through April 2022.Eligibility criteria for selecting studies We included a tool, if it addressed quality concerns of NRSIs and was published in English (unless from grey literature). A tool was excluded, if it was only for diagnostic, prognostic, qualitative or secondary studies.Data extraction and synthesis Two independent researchers searched, screened and reviewed all included studies and tools, summarised quality items and scored whether and to what extent a quality item was described by a tool, for either methodological quality or reporting.Results Forty-nine tools met inclusion criteria and were included for the content analysis. Concerns regarding the quality of NRSI were categorised into 4 domains and 26 items. The Research Triangle Institute Item Bank (RTI Item Bank) and STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) were the most comprehensive tools for methodological quality and reporting, respectively, as they addressed (n=20; 17) and sufficiently described (n=18; 13) the highest number of items. However, none of the tools covered all items.Conclusion Most of the tools have their own strengths, but none of them could address all quality concerns relevant to NRSIs. Even the most comprehensive tools can be complemented by several items. We suggest decision-makers, researchers and tool developers consider the quality-item level heterogeneity, when selecting a tool or identifying a research gap.OSF registration number OSF registration DOI (https://doi.org/10.17605/OSF.IO/KCSGX).
引用
收藏
页数:15
相关论文
共 50 条
  • [31] A FAIR Approach to Real-World Health Data Management and Analysis
    Almeida, Joao Rafael
    Silva, Jorge Miguel
    Oliveira, Jose Luis
    2023 IEEE 36TH INTERNATIONAL SYMPOSIUM ON COMPUTER-BASED MEDICAL SYSTEMS, CBMS, 2023, : 892 - 897
  • [32] Drug repurposing using real-world data; a scoping review
    Tan, George S. Q.
    Sloan, Erica K.
    Lambert, Pete
    Kirkpatrick, Carl M.
    Ilomaki, Jenni
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 545 - 545
  • [33] Clinical research using real-world data: A narrative review
    Kimura, Yuya
    Jo, Taisuke
    Matsui, Hiroki
    Yasunaga, Hideo
    RESPIRATORY INVESTIGATION, 2024, 62 (06) : 929 - 934
  • [34] THE USE AND VALIDATION OF ONCOLOGY ENDPOINT PROXIES IN REAL-WORLD STUDIES: TARGETED LITERATURE REVIEW MAPPING 64 RETROSPECTIVE AND VALIDATION REAL-WORLD STUDIES
    Oikonomidi, T.
    Ingleby, F.
    Saglimbene, V
    Paparrodopoulos, S.
    Teoh, C.
    Rtveladze, K.
    Ralphs, E.
    VALUE IN HEALTH, 2024, 27 (12) : S575 - S575
  • [35] ASSESSMENT OF SURROGATE ENDPOINTS IN REAL-WORLD ONCOLOGY STUDIES, A SYSTEMATIC LITERATURE REVIEW
    Wang, Y.
    Liu, S.
    Rogers, J.
    Winterstein, A. G.
    Burcu, M.
    VALUE IN HEALTH, 2024, 27 (06) : S210 - S210
  • [36] STUDIES ON ECONOMIC BURDEN OF DISEASE USING REAL-WORLD HEALTHCARE DATA IN JAPAN: A SYSTEMATIC REVIEW
    Kuan, W. Y.
    Demiya, S.
    Yu, E.
    Piao, Y.
    VALUE IN HEALTH, 2018, 21 : S51 - S52
  • [37] The Mortality from Hereditary Angioedema Worldwide: a Review of the Real-World Data Literature
    Minafra, Fernanda Gontijo
    Goncalves, Tifany Rafaely
    Alves, Thais Martins
    Pinto, Jorge Andrade
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2022, 62 (01) : 232 - 239
  • [38] What Is Real-World Data? A Review of Definitions Based on Literature and Stakeholder Interviews
    Makady, Amr
    de Boer, Anthonius
    Hillege, Hans
    Klungel, Olaf
    Goettsch, Wim
    VALUE IN HEALTH, 2017, 20 (07) : 858 - 865
  • [39] Integrated electronic health record tools to access real-world data in oncology research
    Casagni, Michelle
    Llewellyn, Nicole
    Kokolus, Maeve
    Chan, Miranda
    Dingwell, Robert
    Chow, Selina
    Campbell, Nancy
    Elrahi, Cassandra
    Piantadosi, Steven
    Quina, Andre
    JAMIA OPEN, 2024, 7 (04)
  • [40] WHAT IS REAL-WORLD DATA?: A REVIEW OF DEFINITIONS BASED ON LITERATURE & STAKEHOLDER INTERVIEWS
    Makady, A.
    de Boer, A.
    Hillege, J. L.
    Klungel, O.
    Goettsch, W.
    VALUE IN HEALTH, 2016, 19 (07) : A502 - A502